Artemis Bioservices is a private, non-profit CRO specialized in vaccine and antiviral evaluation. 

Vision of Artemis Bioservices: The vision of Artemis Bioservices is to become a strategic partner in the process of antiviral, antibody and vaccine development against emerging viral diseases. 

Mission of Artemis Bioservices: To assist biotech and biopharmaceutical companies to accelerate the development and licensing of safe and effective antiviral intervention strategies, in particular against emerging, zoonotic and arboviral diseases, by offering customized in-vitro testing and in-vivo immunogenicity and efficacy testing capabilities

Artemis Bioservices provides high quality preclinical and clinical services to developers of antiviral intervention strategies who want to evaluate the immunogenicity and efficacy of candidate products, especially against emerging, vector-borne and zoonotic viruses. Artemis Bioservices has recently been certified GLP compliant. 

Artemis Bioservices is located in the Yes!Delft Labs building, at Molengraaffsingel 10, 2629 JD, Delft, The Netherlands.

Biotechnology

Life Sciences

Pharmaceutical

Artemis Bioservices (formerly known as Artemis Bio-Support)

Byron Martina

Ruud Van Hofwegen

Martin Schutten

The Leadership Team at Artemis Bioservices is responsible for guiding the strategic direction and operational efficiency of the organization. Comprising the Chief Scientific Officer (CSO), Chief Executive Officer (CEO), and Chief Financial Officer (CFO), this team focuses on fostering collaborations with biotech and biopharmaceutical companies, ensuring alignment with the company’s vision of advancing antiviral and vaccine development against emerging viral diseases, while overseeing financial sustainability and scientific integrity.

Leadership Team

About

Team members

Other teams at Artemis Bioservices (formerly known as Artemis Bio-Support)

Research and Development Team